We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+2.36%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22.4B
AUM Growth
+$153M
Cap. Flow
-$1.08B
Cap. Flow %
-4.8%
Top 10 Hldgs %
13.8%
Holding
1,474
New
155
Increased
445
Reduced
544
Closed
111

Top Buys

Rank Stock Value
1
CAG icon
Conagra Brands
CAG
+$72.5M
2
COP icon
ConocoPhillips
COP
+$70M
3
PEP icon
PepsiCo
PEP
+$60.2M
4
TJX icon
TJX Companies
TJX
+$57.6M
5
DG icon
Dollar General
DG
+$57M

Top Sells

Rank Stock Value
1
STJ
St Jude Medical
STJ
+$122M
2
SBUX icon
Starbucks
SBUX
+$69M
3
MO icon
Altria Group
MO
+$64.7M
4
RTX icon
RTX Corp
RTX
+$63.2M
5
UBS icon
UBS Group
UBS
+$56.2M

Sector Composition

Rank Sector Weight
1 Healthcare 17.92%
2 Technology 12.76%
3 Miscellaneous 10.7%
4 Financials 10.43%
5 Industrials 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGND
651
DELISTED
PRESS GANEY HOLDINGS INC COM STK (DE)
PGND
$2.82M 0.01%
+71,650
New +$2.4M
PARA
652
DELISTED
Paramount Global Class B
PARA
$2.82M 0.01%
51,769
SCL icon
653
Stepan Co
SCL
$1.4B
$2.81M 0.01%
47,200
MFC icon
654
Manulife Financial
MFC
$72.7B
$2.79M 0.01%
205,020
-18,580
-8% -$265K
HUM icon
655
Humana
HUM
$47.6B
$2.79M 0.01%
15,500
-2,800
-15% -$497K
CAL icon
656
Caleres
CAL
$425M
$2.78M 0.01%
115,000
+2,900
+3% +$71.3K
ABUS icon
657
Arbutus Biopharma
ABUS
$1B
$2.76M 0.01%
792,358
+11,062
+1% +$46.8K
INN
658
Summit Hotel Properties
INN
$619M
$2.76M 0.01%
208,200
+25,400
+14% +$303K
CWT icon
659
California Water Service
CWT
$2.96B
$2.74M 0.01%
78,400
+3,600
+5% +$106K
CHSP
660
DELISTED
Chesapeake Lodging Trust
CHSP
$2.74M 0.01%
117,759
+86,859
+281% +$2.1M
CDW icon
661
CDW
CDW
$19.2B
$2.73M 0.01%
68,248
+20,174
+42% +$837K
POT
662
DELISTED
Potash Corp Of Saskatchewan
POT
$2.73M 0.01%
169,024
-5,729
-3% -$95.9K
MANT
663
DELISTED
Mantech International Corp
MANT
$2.72M 0.01%
72,000
+5,200
+8% +$178K
AGIO icon
664
Agios Pharmaceuticals
AGIO
$1.96B
$2.72M 0.01%
64,967
-2,675
-4% -$132K
KLAC icon
665
KLA
KLAC
$220B
$2.72M 0.01%
371,000
-475,000
-56% -$3.41M
PCAR icon
666
PACCAR
PCAR
$64.5B
$2.67M 0.01%
77,250
-9,600
-11% -$353K
LITE icon
667
Lumentum
LITE
$75.3B
$2.66M 0.01%
+110,000
New +$2.73M
OTEX icon
668
Open Text
OTEX
$5.73B
$2.66M 0.01%
90,354
-35,574
-28% -$1.01M
DBS
669
DELISTED
Invesco DB Silver Fund
DBS
$2.64M 0.01%
88,890
-3,160
-3% -$84.6K
GIMO
670
DELISTED
Gigamon Inc.
GIMO
$2.62M 0.01%
+70,000
New +$2.23M
COKE icon
671
Coca-Cola Consolidated
COKE
$13.2B
$2.61M 0.01%
177,000
+141,000
+392% +$2.06M
SABR icon
672
Sabre
SABR
$843M
$2.58M 0.01%
+96,110
New +$2.7M
COHR icon
673
Coherent
COHR
$53.1B
$2.57M 0.01%
137,000
+11,200
+9% +$229K
VPL icon
674
Vanguard FTSE Pacific ETF
VPL
$8.56B
$2.57M 0.01%
46,100
+14,000
+44% +$781K
STX icon
675
Seagate
STX
$176B
$2.51M 0.01%
103,000

Similar funds

Axa's Q2 2016 Portfolio in Review

As of Q2 2016, Axa held 1,474 positions worth $22.4B, up 0.69% from $22.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa withdrew a net $1.08B in Q2 2016, closing 111 positions and reducing 544 holdings. Its most notable exit was MCGRAW-HILL FINANCIAL INC COM, an estimated $23.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Miscellaneous.

Against the trend, Axa opened a new position in Willis Towers Watson worth $32.3M.

  • Axa's largest Q2 2016 buy was Willis Towers Watson: 260,003 shares worth $32.3M.
  • Axa added most to Conagra Brands in Q2 2016, an estimated $72.5M increase.
  • Axa's biggest Q2 2016 reduction was St Jude Medical, cutting an estimated $122M.
  • Axa fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $23.5M.
  • Axa's ten largest holdings make up 14% of its $22.4B portfolio in Q2 2016.
  • Axa opened 155 new positions and closed 111 in Q2 2016.
  • Axa's portfolio value rose 0.69% quarter-over-quarter to $22.4B.

Based on Axa's 13F filing for Q2 2016, filed 11 Aug 2016.